Journal Title：Acta Cardiologica Sinica

Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.

《心臟病學報》歡迎所有與心血管醫(yī)學相關(guān)的論文投稿，包括基礎研究、血管生物學、臨床藥理學、臨床試驗、重癥醫(yī)學、冠心病、介入心臟病學、心律失常與電生理、動脈粥樣硬化、高血壓、心肌病與心力衰竭、心臟瓣膜與結(jié)構(gòu)疾病、小兒心臟病學、心血管外科等。本期刊收到來自全球20多個國家和地區(qū)的論文。目前，《心臟病學報》投稿論文中，臺灣占40%，中國大陸占20%，其他國家占20%，一般投稿率在50%左右。

Acta Cardiologica Sinica創(chuàng)刊于1985年，由Republic of China Society of Cardiology出版商出版，收稿方向涵蓋醫(yī)學 - 心血管系統(tǒng)全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)1.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。